Related Experiment Video
Updated: Mar 30, 2026

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
Published on: June 6, 2025
The Challenges of Blood Pressure Control in Dialysis Patients
Vito M Campese1, Ravi Lakdawala
1Keck School of Medicine, USC, 2020 Zonal Ave, Los Angeles, CA 90033, USA. campese@usc.edu.
Insights
Hypertension is common in chronic kidney disease (CKD) and end-stage kidney disease (ESRD). This review addresses challenges in defining, diagnosing, and managing hypertension in these patients, including drug considerations.
Area of Science:
- Nephrology
- Cardiovascular Medicine
- Clinical Pharmacology
Background:
- Hypertension is highly prevalent in patients with chronic kidney disease (CKD) and end-stage kidney disease (ESRD).
- Significant challenges remain in the definition, variability, diagnosis, and management of hypertension within this patient population.
- Unresolved clinical issues necessitate a comprehensive review of current practices.
Purpose of the Study:
- To critically review the current challenges in defining, diagnosing, and treating hypertension in CKD and ESRD patients.
- To examine the pharmacokinetics, pharmacodynamics, and safety profiles of antihypertensive drugs commonly used in these patients.
- To provide insights into optimizing hypertension management in kidney disease.
Main Methods:
- Literature review of current clinical practice guidelines and research.
- Critical analysis of diagnostic criteria and therapeutic strategies for hypertension in CKD/ESRD.
- Review of pharmacokinetic and pharmacodynamic data for antihypertensive medications.
Main Results:
- Identified significant gaps and controversies in hypertension definition and diagnosis in CKD/ESRD.
- Highlighted variability in blood pressure readings and treatment responses.
- Summarized the evidence on various antihypertensive drug classes, noting specific considerations for kidney patients.
Conclusions:
- Effective management of hypertension in CKD and ESRD requires addressing current clinical practice challenges.
- Understanding drug pharmacokinetics, pharmacodynamics, and safety is crucial for effective antihypertensive therapy in kidney disease.
- Further research is needed to refine diagnostic and therapeutic approaches for hypertension in CKD/ESRD patients.
Abstract:
Hypertension is very prevalent among patients with chronic kidney disease (CKD) and end-stage kidney disease (ESRD). However, there are still several unsolved issues pertaining to the definition, variability, diagnosis and management of hypertension in these patients. This manuscript critically reviews the current challenges in clinical practice in defining, diagnosing and treating hypertension in CKD and ESRD patients. Moreover, the manuscript reviews the pharmacokinetics, pharmacodynamics and safety of most anti-hypertensive drugs used in the management of these patients.
Related Concept Videos
Hemodialysis III: Nursing Management
Hemodialysis II: Procedure and Complications
Dialysis
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Dialysis
Hypertension and Regulation of Blood Pressure
Blood Pressure
The average BP in an adult is typically around 120/80 mmHg (millimeters of mercury). In this measurement, the numerator (120) indicates the systolic pressure, which is the pressure in the arteries during the contraction of the heart's ventricles as blood is expelled. The denominator (80) represents the...

